Participants

Convergence Forum East is an invitation-only gathering of one hundred pharmaceutical executives, biotech entrepreneurs, medical device innovators, academic researchers, and life sciences investors from the Northeast and beyond. Request an invitation.

Companies that will be represented at Convergence Forum East 2013 include:

Accele Biopharma, Inc. GNS Healthcare
Acetylon Pharmaceuticals, Inc. Greenleaf Health, LLC
Adimab LLC Halloran Consulting Group
Agenus Health Advances
Agios Pharmaceuticals Histogenics
Aileron Therapeutics Idera Pharmaceuticals
Aldea Pharmaceuticals Infinity Pharmaceuticals
Alexandria Real Estate Equities Johnson & Johnson
Alnylam Pharmaceuticals Kala Pharmaceuticals
Aquilo Partners, L.P. Liquidia Technologies
AstraZeneca R&D MacDougall Biomedical Communications
Atlas Venture MBio Diagnostics, Inc.
Atterocor, Inc. Merck
Avila Therapeutics Mersana Therapeutics
Back Bay Life Science Advisors Millennium: The Takeda Oncology Company
Biogen Idec Momenta Pharmaceuticals
Bluebird Bio Nine Point Medical
BluePrint Medicines Novartis Venture Funds
Boehringer Venture Fund Novelos Therapeutics, Inc.
Boston Biochem, Inc. OvaScience
Boston Consulting Group Oxyrane Limited
Bristol-Myers Squibb Patheon, Inc.
BTG International Inc. PatientsLikeMe
Calorics Inc. Puretech Ventures
Canaan Partners Red Sky Partners
CBT Advisors Rhapsody Biologics
Celgene RMG Associates, LLC
Cold Spring Pharmaceuticals RRD Intl.
Cubist Pharmaceuticals RS Consulting
Danforth Advisors Sanofi
DeuteRx, LLC Satori Pharmaceuticals Inc.
Diagnostic Laboratory Systems Inc. Scholar Rock, LLC
Dohmen Shire Human Genetic Therapies
Dyax Corp. SR One
Enumeral Biomedical Corp. Strategic Science & Technologies, LLC
Enzymatics Sunovion Pharmaceuticals Inc.
EpiZyme Inc. SV Biosystems 
Euromedica SynapDx
Extrovertic Targacept
Fidelity Biosciences The Leukemia & Lymphoma Society
Flagship Ventures Transparency Life Sciences
Foley and Lardner LLP Warp Drive Bio
General Catalyst Partners WBUR-FM
Zafgen Inc.